肝硬化从代偿期到肝肾综合征的心血管映射:一项磁共振研究
这项前瞻性队列研究纳入87例肝硬化患者和27例健康对照,用磁共振测量门静脉压力及区域血流。结果显示从代偿期到失代偿期再到肝肾综合征-急性肾损伤存在三个血流动力学阶段;肝肾综合征-急性肾损伤患者心输出量最高而肾血流最低,磁共振似为可靠的无创血流动力学评估方法。
要点
- 代偿期肝硬化患者奇静脉血流和肝动脉血流占心指数比例高于对照(P<0.01)。
- 失代偿期较代偿期心指数更高、肠系膜上动脉血流更高、全身血管阻力更低。
- 肝肾综合征-急性肾损伤患者心输出量最高、肾血流最低,肾灌注减低与高心输出量并存。
核心结论
- 区域心循环变化似与临床症状密切相关,从代偿期到失代偿期再到肝肾综合征-急性肾损伤存在三个不同的血流动力学阶段。
- 肝肾综合征-急性肾损伤患者心输出量高而肾灌注减低,这对心脏功能障碍是肝肾综合征-急性肾损伤病因的现行病理生理假说提出挑战。
- 磁共振成像似乎是评估血流动力学准确可靠的无创方法,有潜力作为肝硬化患者的诊断工具。
研究设计与样本
- 前瞻性队列研究,纳入87例肝硬化患者和27例健康对照。
- 肝硬化患者包括代偿期27例和失代偿期60例;失代偿期进一步分为可缓解腹水33例、难治性腹水16例和肝肾综合征-急性肾损伤11例。
- 测量门静脉压力,并用磁共振成像评估区域血流。
主要发现
- 代偿期肝硬化患者奇静脉血流和肝动脉血流占心指数比例高于健康对照(P<0.01),其他血流参数无显著差异。
- 失代偿期肝硬化患者较代偿期患者心指数更高(P<0.01)、肠系膜上动脉血流更高(P=0.01)、全身血管阻力更低(P<0.001)。
- 肝肾综合征-急性肾损伤患者在所有组中心输出量最高(P<0.01)、肾血流最低(P=0.02)。
- 单血流动力学参数与终末期肝病模型的关联强于与门静脉压力的关联。
关键数值与推荐
- 代偿期肝硬化患者奇静脉血流和肝动脉血流占心指数比例高于健康对照(P<0.01)。
- 失代偿期较代偿期患者心指数升高(P<0.01)、肠系膜上动脉血流升高(P=0.01)、全身血管阻力降低(P<0.001)。
- 肝肾综合征-急性肾损伤患者心输出量最高(P<0.01)、肾血流最低(P=0.02)。
临床怎么用
- 磁共振成像似乎是评估肝硬化患者血流动力学准确可靠的无创方法,有潜力作为诊断工具。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Arterial vasodilation and hyperdynamic circulation are considered hallmarks of the pathophysiological mechanisms of decompensation in cirrhosis. However, detailed characterization of peripheral, splanchnic, renal, and cardiac hemodynamic have not previously been published in a spectrum from healthy stage to advanced decompensated liver disease with hepatorenal syndrome-acute kidney injury (HRS-AKI). METHODS: We included 87 patients with cirrhosis and 27 healthy controls in this prospective cohort study. The population comprised patients with compensated cirrhosis (n = 27) and decompensated cirrhosis (n = 60); patients with decompensated cirrhosis were further separated into subsets of responsive ascites (33), refractory ascites (n = 16), and HRS-AKI (n = 11). We measured portal pressure and assessed regional blood flow by magnetic resonance imaging. RESULTS: Patients with compensated cirrhosis experienced higher azygos venous flow and higher hepatic artery flow fraction of cardiac index than controls ( P < 0.01), but other flow parameters were not significantly different. Patients with decompensated cirrhosis experienced significantly higher cardiac index ( P < 0.01), higher superior mesenteric artery flow ( P = 0.01), and lower systemic vascular resistance ( P < 0.001) compared with patients with compensated cirrhosis. Patients with HRS-AKI had the highest cardiac output and lowest renal flow of all groups ( P < 0.01 and P = 0.02, respectively). Associations of single hemodynamic parameters were stronger with model for end-stage liver disease than with portal pressure. DISCUSSION: The regional cardiocirculatory changes seem closely linked to clinical symptoms with 3 distinguished hemodynamic stages from compensated to decompensated cirrhosis and, finally, to HRS-AKI. The attenuated renal perfusion despite high cardiac output in patients with HRS-AKI challenges the prevailing pathophysiological hypothesis of cardiac dysfunction as a causal factor in HRS-AKI. Finally, magnetic resonance imaging seems an accurate and reliable noninvasive method to assess hemodynamics and has potential as a diagnostic tool in patients with cirrhosis.
引用
- Danielsen KV, Wiese S, Busk T, et al. Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study. Am J Gastroenterol. 2022. PMID: 35916685. doi:10.14309/ajg.0000000000001847
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。